# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-017808
Filing Date
2020-04-22
Accepted
2020-04-22 07:01:40
Documents
20
Period of Report
2020-04-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | bntx-6k_20200422.htm | 6-K | 18583
2 | EX-99.1 | bntx-ex991_7.htm | EX-99.1 | 36007
3 | EX-99..2 | bntx-ex992_68.htm | EX-99..2 | 15139
4 | GRAPHIC | gna1qb4r0ghq000013.jpg | GRAPHIC | 230548
5 | GRAPHIC | gna1qb4r0ghq000009.jpg | GRAPHIC | 280885
6 | GRAPHIC | gna1qb4r0ghq000005.jpg | GRAPHIC | 263720
7 | GRAPHIC | gxsdiooyegbt000002.jpg | GRAPHIC | 21283
8 | GRAPHIC | gna1qb4r0ghq000014.jpg | GRAPHIC | 269113
9 | GRAPHIC | gna1qb4r0ghq000006.jpg | GRAPHIC | 63467
10 | GRAPHIC | gna1qb4r0ghq000004.jpg | GRAPHIC | 325396
11 | GRAPHIC | gna1qb4r0ghq000011.jpg | GRAPHIC | 301585
12 | GRAPHIC | gxsdiooyegbt000001.jpg | GRAPHIC | 6330
13 | GRAPHIC | gna1qb4r0ghq000008.jpg | GRAPHIC | 297014
14 | GRAPHIC | gna1qb4r0ghq000002.jpg | GRAPHIC | 433527
15 | GRAPHIC | gna1qb4r0ghq000010.jpg | GRAPHIC | 331997
16 | GRAPHIC | gna1qb4r0ghq000003.jpg | GRAPHIC | 194494
17 | GRAPHIC | gna1qb4r0ghq000007.jpg | GRAPHIC | 303789
18 | GRAPHIC | gna1qb4r0ghq000012.jpg | GRAPHIC | 335247
19 | GRAPHIC | gna1qb4r0ghq000015.jpg | GRAPHIC | 225542
20 | GRAPHIC | gna1qb4r0ghq000001.jpg | GRAPHIC | 245976
| Complete submission text file | 0001564590-20-017808.txt |  | 5760465

Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 20806620
SIC: 2836 Biological Products, (No Diagnostic Substances)